Abstract: A product and method of manufacturing and producing antimicrobial fibers using an antimicrobial additive material. The method comprising using various antimicrobial metals incorporated and embedded into an inorganic material as metal ions within the additive material that can be formulated into a masterbatch precursor material and processed to manufacture fine or synthetic fibers using standard manufacturing processes for use in applications from face masks and respirators to air filters for HVAC and higher efficiency HEPA applications.

Abstract: A method for removing at least one odorous contaminant from a fluid stream by filtering the fluid stream with a filtration medium. The filtration medium includes a chemically modified activated carbon. The method is useful for removing one or more volatile organic compounds and/or one or more volatile thiol compounds, particularly terpenes (e.g., alpha-pinene and myrcene), nonanol, decanol, o-cymene, and benzaldehyde from the fluid stream. In some embodiments, the fluid stream is a cannabis grow house exhaust stream.

Abstract: Techniques are described for preparing a water filtration composition that includes activated carbon having an ash content of at least 10 wt. % and particles of a solubilizing agent. The solubilizing agent forms a water-soluble complex with cations (e.g., calcium ions). This increases the solubility of calcium ions and other scale-forming ions in water, thus suppressing scale formation on interior surfaces of water processing infrastructure. The activated carbon and the solubilizing agent are processed to have particle sizes in a same range, thus enabling the activated carbon and the solubilizing agent to be thoroughly mixed together.

Abstract: Techniques are described for preparing a water filtration composition that includes activated carbon having an ash content of at least 10 wt. % and particles of a solubilizing agent. The solubilizing agent forms a water-soluble complex with cations (e.g., calcium ions). This increases the solubility of calcium ions and other scale-forming ions in water, thus suppressing scale formation on interior surfaces of water processing infrastructure. The activated carbon and the solubilizing agent are processed to have particle sizes in a same range, thus enabling the activated carbon and the solubilizing agent to be thoroughly mixed together.

Abstract: A method for removing sulfur containing compounds from petroleum liquid. The method includes contacting the petroleum liquid with an activated carbon that has a high ash content, a high metal content and a significant amount of meso and macro porosity.

Abstract: The present invention relates to the synergistic combination of the short and long Rod-Derived Cone Viability Factors and to methods for treating retinal degenerative diseases.

Abstract: A method for removing sulfur containing compounds from petroleum liquid. The method includes contacting the petroleum liquid with an activated carbon that has a high ash content, a high metal content and a significant amount of meso and macro porosity.

Abstract: Disclosed herein are dry blend compositions comprising: a hydrated lime having a Ca(OH)2 content of at least 94% by weight, the hydrated lime being present in an amount ranging from 1% to 40% by weight relative to the total weight of the composition; and an activated carbon present in an amount of at least 60% by weight relative to the total weight of the composition. Also disclosed are methods of mercury removal from flue gases, such as flue gases generated from coal-fired power plants.

Abstract: The present invention relates to the identification of microRNAs that regulate smooth muscle cell proliferation and differentiation, including the miR-143/miR-145 cluster. Methods of treating restenosis and neointima formation by increasing expression of miR-143 and/or miR-145 are disclosed. The present invention also relates to the identification of two microRNAs, miR-486 and miR-422a, that regulate cell survival in the heart. Methods of treating or preventing cardiac hypertrophy, heart failure, or myocardial infarction by increasing expression of miR-486 and/or miR-422a in heart tissue are also disclosed.

Abstract: The present invention relates to the identification of microRNAs that regulate smooth muscle cell proliferation and differentiation, including the miR-143/miR-145 cluster. Methods of treating restenosis and neointima formation by increasing expression of miR-143 and/or miR-145 are disclosed. The present invention also relates to the identification of two microRNAs, miR-486 and miR-422a, that regulate cell survival in the heart. Methods of treating or preventing cardiac hypertrophy, heart failure, or myocardial infarction by increasing expression of miR-486 and/or miR-422a in heart tissue are also disclosed.

Abstract: The present invention relates to the identification of microRNAs that regulate smooth muscle cell proliferation and differentiation, including the miR-143/miR-145 cluster. Methods of treating restenosis and neointima formation by increasing expression of miR-143 and/or miR-145 are disclosed. The present invention also relates to the identification of two microRNAs, miR-486 and miR-422a, that regulate cell survival in the heart. Methods of treating or preventing cardiac hypertrophy, heart failure, or myocardial infarction by increasing expression of miR-486 and/or miR-422a in heart tissue are also disclosed.

Abstract: The disclosed device is directed toward magneto-rheological fluid encasement device. The magneto-rheological fluid encasement device comprises a body having at least one containment element defining an interior and an exterior. A magneto-rheological fluid is disposed in the interior of the at least one containment element. At least one magnetic field is in operative communication with the magneto-rheological fluid.